Increasing evidence suggests that herbal-derived exosome-like nanoparticles (ELNs) can easily cross biological barriers such as the blood-brain barrier (BBB). However, current understanding of ELNs application in ischemic stroke therapy is still in its infancy.
Method
We extracted nanoparticles (TGD-NPs) from Tianma Gouteng decoction (TGD) and characterized their morphology and main active compounds. Subsequently, the potential and functional mechanism of TGD-NPs in maintaining the integrity of the BBB were evaluated in middle cerebral artery occlusion (MCAO)-induced ischemic stroke model and oxygen-glucose deprivation/reperfusion (OGD/R)-stimulated cell model.
Result
We successfully extracted NPs, which retains the main bioactive compounds of TGD: baicalin, emodin, gastrodin, and stachydrine. Functional studies indicated that in mouse MCAO model, TGD-NPs intervention was more effective than TGD preparations in maintaining the integrity of the BBB, reducing the infarct area, and improving the neurological function. Meanwhile, TGD-NPs treatment attenuated the decrease in cell viability caused by OGD/R, and it significantly enhanced expression of tight junction proteins (Occludin and ZO-1). Mechanistic exploration revealed that TGD-NPs markedly upregulated lncRNA OIP5-AS1 expression, and its beneficial effect was attributed to the activation of the S1PR1-ERK1/2-MEK1/2 signaling axis.
Conclusion
TGD-NPs are positive in maintaining BBB integrity and neurological function after ischemic stroke.
AderintoNOlatunjiGKokoriE, et al.miR-210 in ischaemic stroke: biomarker potential, challenges and future perspectives. Eur J Med Res2024; 29: 432.
2.
Isordia-SalasISantiago-GermánDJiménez-AlvaradoRM, et al.Genetic variants associated with high susceptibility of premature ischemic stroke. J Renin-Angiotensin-Aldosterone Syst JRAAS2023; 2023: 9002021.
3.
JiaJJiaoWWangG, et al.Drugs/agents for the treatment of ischemic stroke: advances and perspectives. Med Res Rev2024; 44: 975–1012.
4.
TangZMengSSongZ, et al.Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity. Mater Today Bio2023; 20: 100674.
5.
YangQYeWLuoD, et al.Neuroprotective effects of anti-TRAIL-ICG nanoagent and its multimodal imaging evaluation in cerebral ischemia-reperfusion injury. Mater Today Bio2024; 26: 101094.
6.
NianKHardingICHermanIM, et al.Blood-Brain barrier damage in ischemic stroke and its regulation by endothelial mechanotransduction. Front Physiol2020; 11: 605398.
7.
GaoH-MChenHCuiG-Y, et al.Damage mechanism and therapy progress of the blood-brain barrier after ischemic stroke. Cell Biosci2023; 13: 196.
8.
QiLWangFSunX, et al.Recent advances in tissue repair of the blood-brain barrier after stroke. J Tissue Eng2024; 15: 20417314241226551.
9.
LiuRZhengYHanT, et al.Angiogenic actions of paeoniflorin on endothelial progenitor cells and in ischemic stroke rat model. Am J Chin Med2021; 49: 863–881.
10.
D'SouzaADaveKMStetlerRA, et al.Targeting the blood-brain barrier for the delivery of stroke therapies. Adv Drug Delivery Rev2021; 171: 332–351.
11.
ZhuTWangLWangL-P, et al.Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: applications for natural compounds from medicinal herbs. Biomed Pharmacother2022; 148: 112719.
12.
WangXChenHSongF, et al.Resveratrol: a potential medication for the prevention and treatment of varicella zoster virus-induced ischemic stroke. Eur J Med Res2023; 28: 400.
13.
FanGLiuMLiuJ, et al.Traditional Chinese medicines treat ischemic stroke and their main bioactive constituents and mechanisms. Phytother Res PTR2024; 38: 411–453.
14.
LuJWeiQ. Treating 60 cases of stroke treted with Tianma Gouteng Yin. Clin J Chin Med2014; 6: 87–88.
15.
XuP. Treating 100 cases of ischemic stroke in the recovery period by modified Tianma Gouteng decoction. Med J Chin People's Health2008; 4: 292.
16.
LeiTFuGXueX, et al.Tianma Gouteng decoction improve neuronal synaptic plasticity and oligodendrocyte apoptosis in Parkinson's disease mice. Phytomedicine2025; 140: 156553.
17.
ZhaoHWangLZhangL, et al.Phytochemicals targeting lncRNAs: a novel direction for neuroprotection in neurological disorders. Biomed Pharmacother2023; 162: 114692.
18.
GuoYYangJ-HHeY, et al.Protocatechuic aldehyde prevents ischemic injury by attenuating brain microvascular endothelial cell pyroptosis via lncRNA Xist. Phytomedicine2022; 94: 153849.
19.
ZhangLCaiQLinS, et al.Qingda granule exerts neuroprotective effects against ischemia/reperfusion-induced cerebral injury via lncRNA GAS5/miR-137 signaling pathway. Int J Med Sci2021; 18: 1687–1698.
20.
ZhangJ-KLiYYuZ-T, et al.OIP5-AS1 Inhibits oxidative stress and inflammation in ischemic stroke through miR-155-5p/IRF2BP2 axis. Neurochem Res2023; 48: 1382–1394.
21.
ChenYLiuWChenM, et al.Up-regulating lncRNA OIP5-AS1 protects neuron injury against cerebral hypoxia-ischemia induced inflammation and oxidative stress in microglia/macrophage through activating CTRP3 via sponging miR-186-5p. Int Immunopharmacol2021; 92: 107339.
22.
RaoYLiJQiaoR, et al.Tetramethylpyrazine and Astragaloside IV have synergistic effects against spinal cord injury-induced neuropathic pain via the OIP5-AS1/miR-34a/Sirt1/NF-κB axis. Int Immunopharmacol2023; 115: 109546.
23.
RaoYLiJQiaoR, et al.Synergistic effects of tetramethylpyrazine and astragaloside IV on spinal cord injury via alteration of astrocyte A1/A2 polarization through the Sirt1-NF-κB pathway. Int Immunopharmacol2024; 131: 111686.
24.
ChenY-XWeiC-XLyuY-Q, et al.Biomimetic drug-delivery systems for the management of brain diseases. Biomater Sci2020; 8: 1073–1088.
25.
HaoYFengLLiuH, et al.Bioactive hydrogel synergizes neuroprotection, macrophage polarization, and angiogenesis to improve repair of traumatic brain injury. Mater Today Bio2024; 29: 101335.
26.
YiQXuZThakurA, et al.Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment. Pharmacol Res2023; 190: 106733.
27.
XuZXuYZhangK, et al.Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities. J Nanobiotechnol2023; 21: 114.
28.
WangRZhangYGuoY, et al.Plant-derived nanovesicles: promising therapeutics and drug delivery nanoplatforms for brain disorders. Fundam Res2025; 5: 830–850.
29.
XiongX-YPanX-RLuoX-X, et al.Astrocyte-derived lactate aggravates brain injury of ischemic stroke in mice by promoting the formation of protein lactylation. Theranostics2024; 14: 4297–4317.
30.
LongaEZWeinsteinPRCarlsonS, et al.Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke1989; 20: 84–91.
31.
WangCLiYZhangY, et al.Triolein alleviates ischemic stroke brain injury by regulating autophagy and inflammation through the AKT/mTOR signaling pathway. Mol Med2024; 30: 242.
32.
YangTLiLPangJ, et al.Modulating intestinal barrier function by sphingosine-1-phosphate receptor 1 specific agonist SEW2871 attenuated ANIT-induced cholestatic hepatitis via the gut-liver axis. Int Immunopharmacol2023; 125: 111150.
33.
LiY-JShiSXLiuQ, et al.Targeted role for sphingosine-1-phosphate receptor 1 in cerebrovascular integrity and inflammation during acute ischemic stroke. Neurosci Lett2020; 735: 135160.
34.
RenYMaXWangT, et al.The cerebroprotein hydrolysate-I plays a neuroprotective effect on cerebral ischemic stroke by inhibiting MEK/ERK1/2 signaling pathway in rats. Neuropsychiatr Dis Treat2021; 17: 2199–2208.
35.
LiCSunTJiangC. Recent advances in nanomedicines for the treatment of ischemic stroke. Acta Pharm Sin B2021; 11: 1767–1788.
36.
IkramMRasheedS. Genetics of Dravet syndrome and its targeted therapy by nanomedicine: a roadmap for future treatment of drug resistant seizures. Curr Mol Pharmacol2023; 16: 475–493.
37.
JiPXuQLiJ, et al.Advances in nanoparticle-based therapeutics for ischemic stroke: enhancing drug delivery and efficacy. Biomed Pharmacother2024; 180: 117564.
38.
AiSLiYZhengH, et al.Collision of herbal medicine and nanotechnology: a bibliometric analysis of herbal nanoparticles from 2004 to 2023. J Nanobiotechnol2024; 22: 140.
39.
GuoXLuoWWuL, et al.Natural products from herbal medicine self-assemble into advanced bioactive materials. Adv Sci2024; 11: e2403388.
40.
XuX-HYuanT-JDadHA, et al.Plant exosomes as novel nanoplatforms for MicroRNA transfer stimulate neural differentiation of stem cells in vitro and in vivo. Nano Lett2021; 21: 8151–8159.
41.
HaoZZhangZZhaoY, et al.Baicalin reduces immune cell infiltration by inhibiting inflammation and protecting tight junctions in ischemic stroke injury. Am J Chin Med2023; 51: 355–372.
42.
LvBZhengKSunY, et al.Network pharmacology experiments show that emodin can exert a protective effect on MCAO rats by regulating Hif-1α/VEGF-A signaling. ACS Omega2022; 7: 22577–22593.
43.
ZhangMZhangYPengJ, et al.Gastrodin against oxidative stress-inflammation crosstalk via inhibiting mtDNA/TLR9 and JAK2/STAT3 signaling to ameliorate ischemic stroke injury. Int Immunopharmacol2024; 141: 113012.
44.
LiLSunLQiuY, et al.Protective effect of stachydrine against cerebral ischemia-reperfusion injury by reducing inflammation and apoptosis through P65 and JAK2/STAT3 signaling pathway. Front Pharmacol2020; 11: 64.
45.
WangXXinCZhouY, et al.Plant-Derived vesicle-like nanoparticles: the next-generation drug delivery nanoplatforms. Pharmaceutics2024; 16: 588.
46.
LiuMWangHYangY, et al.Therapeutic potential of plant-derived exosome-like nanoparticles for CNS diseases: advancements in preparation and characterization. Ann Med2025; 57: 2537345.
47.
SmithKRBorchardtRT. Permeability and mechanism of albumin, cationized albumin, and glycosylated albumin transcellular transport across monolayers of cultured bovine brain capillary endothelial cells. Pharm Res1989; 6: 466–473.
48.
LockmanPRKoziaraJMMumperRJ, et al.Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Targeting2004; 12: 635–641.
49.
RazaviZSRazaviFSAlizadehSS. Inorganic nanoparticles and blood-brain barrier modulation: advancing targeted neurological therapies. Eur J Med Chem2025; 287: 117357.
50.
AsimakidouETanJKSZengJ, et al.Blood-Brain barrier-targeting nanoparticles: biomaterial properties and biomedical applications in translational neuroscience. Pharmaceuticals2024; 17: 612.
51.
UlitskyIShkumatavaAJanCH, et al.Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell2011; 147: 1537–1550.
52.
ZhuXLiSDingH, et al.Long non-coding RNA OIP5-AS1 protects neurons from ischemia-reperfusion injury and inhibits neuronal apoptosis through TAB-2. Biochem Biophys Res Commun2025; 743: 151139.
53.
SolivenBMironVChunJ. The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. Neurology2011; 76: S9–14.
54.
IchijoMIshibashiSLiF, et al.Sphingosine-1-Phosphate receptor-1 selective agonist enhances collateral growth and protects against subsequent stroke. PloS One2015; 10: e0138029.
55.
LiHZhouXLiY, et al.The selective sphingosine 1-phosphate receptor 1 modulator RP101075 improves microvascular circulation after cerebrovascular thrombosis. FASEB J2019; 33: 10935–10941.
56.
WangJDingXLiC, et al.Early exercise intervention promotes myelin repair in the brains of ischemic rats by inhibiting the MEK/ERK pathway. Transl Neurosci2024; 15: 20220335.
57.
SchanbacherCBieberMReindersY, et al.ERK1/2 activity is critical for the outcome of ischemic stroke. Int J Mol Sci2022; 23: 706.
58.
ZhangSDuWDongH. Study on the migrated components of Tianma Gouteng decoction in vitro and in rat blood based on UPLC/Q-TOF MS technology. J Li-Shizhen Tradit Chin Med2021; 32: 1115–1119.
59.
DuanJZhangJWangX, et al.Treatment of neurological diseases with Tianma Goutengyin： A review. Chin J Exp Trad Med Formulae2024; 30: 255–264.
60.
BaiCLiuJZhangX, et al.Research status and challenges of plant-derived exosome-like nanoparticles. Biomed Pharmacother2024; 174: 116543.
